People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Excision BioTherapeutics Inc | — | Biotechnology | Series C | $71.2M | $338.5M | 2021 |
| Terraphase Engineering Inc. | — | Other | Pre-Seed | $305K | $1.9M | 2023 |
William Carson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Carson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ashok Krishnamurthi | 1 | 8 |
| Vasudev Bailey | 1 | 5 |
| Peter Zawislanski | 1 | 1 |
| Christopher Voci | 1 | 1 |
| Nader Sherif | 1 | 1 |
| Jeffery Raines | 1 | 1 |
| Melissa Schuetz | 1 | 1 |
| Daniel Dornbusch | 1 | 1 |
| Andrew Romolo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.